Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the safety and immunogenicity of the HAVpur Hepatitis A vaccine in healthy young children has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• HAVpur

Snippet

Sponsor: Crucell Holland BV | Conditions: Hepatitis A | Phase 4 | Status: COMPLETED | Results posted: 2013-12-17